|
EP1922321A1
|
|
Pyrazoloý1,5-a¨pyrimidine compounds and pharmaceutical compositions containing them
|
|
GB0526430D0
|
|
Antineoplastic compound
|
|
GB0516378D0
|
|
Compound
|
|
GB0505416D0
|
|
Proteins involved in apoptosis
|
|
GB0505417D0
|
|
Proteins involved in apoptosis
|
|
GB0405768D0
|
|
Proteins involved in apoptosis
|
|
GB0405770D0
|
|
Proteins involved in apoptosis
|
|
US2005019746A1
|
|
Apoptosis-related kinase/GPCRs
|
|
EP1588163A2
|
|
Kinases and gpcrs involved in apoptosis
|
|
AU2003229930A1
|
|
A role for survivin in apoptosis of myeloid cells
|
|
GB0305267D0
|
|
Proteins involved in apoptosis
|
|
GB0305269D0
|
|
Proteins involved in apoptosis
|
|
GB0305268D0
|
|
Proteins involved in apoptosis
|
|
GB0301566D0
|
|
Kinasaes and GPCRs involved in apoptosis
|
|
AU2002352459A1
|
|
Early stage redox-related apoptosis modulator-2 (esram-2)
|
|
AU2002347368A1
|
|
P55pik
|
|
AU2002327945A1
|
|
Human delta-n p73 molecules and uses thereof
|
|
GB0200831D0
|
|
p55PIK
|
|
GB0129846D0
|
|
Tgnp
|
|
GB0128753D0
|
|
Daxx variants
|
